Dr. Omar Danoun, MD

Dr. Danoun practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Danoun's NPI, 1316374812, was assigned on September 30, 2013. Dr. Danoun graduated from Al-Quds University in 2011. Dr. Danoun holds Michigan license 4301103886.

Dr. Danoun's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Danoun's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Danoun is also affiliated with Henry Ford West Bloomfield Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Danoun to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danoun practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Danoun's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Danoun is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Danoun's licenses on file in 3 states: Michigan, Florida and Minnesota.

Dmand AI lists encephalopathy, epilepsy and migraine and chronic headache among the conditions Dr. Danoun treats.

CMS data shows 150 Medicare services from Dr. Danoun across 5 procedure codes in 2024, for 140 Medicare patients. Medicare paid $10,587 for them.

CMS counts 140 Medicare patients who saw Dr. Danoun in 2024. The largest group is under 65, with 51 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Danoun's median patient age at 55, with 50% women.

In 2024, Dr. Danoun wrote 1,475 Medicare Part D claims for 135 patients. 69% of them were for generic drugs. CMS names the drug for 1,342 of them, across 25 drugs with 11 or more claims each, at $641,099 in total drug cost. In 2023, CMS named 1,265 claims across 24 drugs.

Dr. Danoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Danoun as offering telehealth.

Dmand AI links 11 papers to Dr. Danoun, published from 2013 to 2023. 2021 was the busiest year, with 4. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Danoun has published most often in Am J Ther. Dr. Danoun's most frequent co-authors are Gregory L. Barkley, MD, Mirela Cerghet, MD, PhD and David P. Harris, MD.

CMS Open Payments shows 37 general payments to Dr. Danoun from 9 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 51% of the total. Neuropace, Inc. paid the most, $2,630.

Dr. Danoun graduated from Al-Quds University in 2011.

Dr. Danoun is in network with 15 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.